Valsamakis A - Search Results

1

Early studies on DNA-based immunizations for measles virus.

Yang K, Mustafa F, Valsamakis A, Santoro JC, Griffin DE, Robinson HL. Yang K, et al. Among authors: valsamakis a. Vaccine. 1997 Jun;15(8):888-91. doi: 10.1016/s0264-410x(96)00261-7. Vaccine. 1997. PMID: 9234540 Free article.

2

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.

Polack FP, Lee SH, Permar S, Manyara E, Nousari HG, Jeng Y, Mustafa F, Valsamakis A, Adams RJ, Robinson HL, Griffin DE. Polack FP, et al. Among authors: valsamakis a. Nat Med. 2000 Jul;6(7):776-81. doi: 10.1038/77506. Nat Med. 2000. PMID: 10888926

3

Strains of measles vaccine differ in their ability to replicate in an damage human thymus.

Valsamakis A, Kaneshima H, Griffin DE. Valsamakis A, et al. J Infect Dis. 2001 Feb 1;183(3):498-502. doi: 10.1086/318073. Epub 2001 Jan 9. J Infect Dis. 2001. PMID: 11133383

4

Altered virulence of vaccine strains of measles virus after prolonged replication in human tissue.

Valsamakis A, Auwaerter PG, Rima BK, Kaneshima H, Griffin DE. Valsamakis A, et al. J Virol. 1999 Oct;73(10):8791-7. doi: 10.1128/JVI.73.10.8791-8797.1999. J Virol. 1999. PMID: 10482633 Free PMC article.

5

Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.

Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, Greer CE, Perri S, Polo JM, Griffin DE. Pan CH, et al. Among authors: valsamakis a. Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11581-8. doi: 10.1073/pnas.0504592102. Epub 2005 Jul 21. Proc Natl Acad Sci U S A. 2005. PMID: 16037211 Free PMC article.

6

Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody.

Polack FP, Auwaerter PG, Lee SH, Nousari HC, Valsamakis A, Leiferman KM, Diwan A, Adams RJ, Griffin DE. Polack FP, et al. Among authors: valsamakis a. Nat Med. 1999 Jun;5(6):629-34. doi: 10.1038/9473. Nat Med. 1999. PMID: 10371500

7

Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo.

Valsamakis A, Schneider H, Auwaerter PG, Kaneshima H, Billeter MA, Griffin DE. Valsamakis A, et al. J Virol. 1998 Oct;72(10):7754-61. doi: 10.1128/JVI.72.10.7754-7761.1998. J Virol. 1998. PMID: 9733811 Free PMC article.

8

Clinical isolates of measles virus use CD46 as a cellular receptor.

Manchester M, Eto DS, Valsamakis A, Liton PB, Fernandez-Muñoz R, Rota PA, Bellini WJ, Forthal DN, Oldstone MB. Manchester M, et al. Among authors: valsamakis a. J Virol. 2000 May;74(9):3967-74. doi: 10.1128/jvi.74.9.3967-3974.2000. J Virol. 2000. PMID: 10756008 Free PMC article.

9

Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle.

McChesney MB, Kehrl JH, Valsamakis A, Fauci AS, Oldstone MB. McChesney MB, et al. Among authors: valsamakis a. J Virol. 1987 Nov;61(11):3441-7. doi: 10.1128/JVI.61.11.3441-3447.1987. J Virol. 1987. PMID: 3499518 Free PMC article.

10

Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones.

Endres MJ, Valsamakis A, Gonzalez-Scarano F, Nathanson N. Endres MJ, et al. Among authors: valsamakis a. J Virol. 1990 May;64(5):1927-33. doi: 10.1128/JVI.64.5.1927-1933.1990. J Virol. 1990. PMID: 2182907 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters